Physician profile
Andreas Muench
NPI 1326027491
$18,448.26
in general payments reported to CMS, 2019-2025
46 companies · $2,153 in 2025
The $2,153 reported for 2025 was more than what 84% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $4,430 · 2020: $1,136 · 2021: $1,059 · 2022: $3,194 · 2023: $1,110 · 2024: $5,368 · 2025: $2,153.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,885 · Travel and Lodging: $3,745.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,885.29 |
| Travel and Lodging | $3,745.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $8,358.71 | 2021-2025 | Corevalve Evolut R, Symplicity G3, Micra |
| Medtronic Vascular, INC. | $3,213.31 | 2019-2020 | |
| Astrazeneca Pharmaceuticals Lp | $705.18 | 2019-2025 | Farxiga |
| Pfizer INC. | $623.64 | 2019-2025 | |
| Amgen INC. | $488.30 | 2019-2025 | Repatha, Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $437.67 | 2019-2025 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $381.53 | 2019-2025 | Camzyos, Eliquis |
| Janssen Pharmaceuticals, INC | $376.32 | 2019-2024 | Xarelto |
| Boston Scientific Corporation | $359.01 | 2019-2025 | Cds - Mct/Cem Monitoring |
| Merck Sharp & Dohme LLC | $326.01 | 2021-2025 | Verquvo |
| Philips North America LLC | $319.95 | 2020-2025 | Ambulatory Monitoring & Diagnostics Undivided, (Cm9) Amb Mon & Diag Und, (5091) Amb Mon & Diag Und |
| Esperion Therapeutics, INC. | $313.12 | 2020-2023 | Nexletol |
| Abiomed | $296.09 | 2019-2025 | |
| Chiesi USA, INC. | $266.66 | 2019-2025 | Kengreal |
| Shockwave Medical, INC | $231.31 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
Show all 44 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $214.19 | 2019-2025 | |
| Sanofi-Aventis U.S. LLC | $168.83 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $160.04 | 2021-2025 | Jardiance |
| Irhythm Technologies, INC. | $144.34 | 2023-2024 | Zio Xt Patch, Zio Monitor |
| Braemar Manufacturing, LLC | $140.83 | 2019 | |
| Amarin Pharma, INC. | $115.29 | 2019-2021 | |
| Edwards Lifesciences Corporation | $100.40 | 2022 | |
| Alnylam Pharmaceuticals INC. | $97.39 | 2024-2025 | Amvuttra |
| Actelion Pharmaceuticals US, INC. | $83.38 | 2019-2021 | |
| Lundbeck LLC | $67.49 | 2020 | |
| Scpharmaceuticals INC. | $66.23 | 2024-2025 | |
| Cardiva Medical, INC. | $54.64 | 2020-2025 | Optomonitor 3, Cardiva Vascade Mvp Vvcs 6-12f |
| Novo Nordisk INC | $33.84 | 2024-2025 | Rybelsus, Ozempic |
| Bardy Diagnostics, INC. | $31.00 | 2020 | |
| Abbott Laboratories | $29.02 | 2025 | Perclose Proglide |
| Ethicon US, LLC | $28.41 | 2025 | Surgicel Nu-Knit, Dermabond Prineo, Vistaseal |
| Gilead Sciences, INC. | $27.20 | 2019 | |
| Inari Medical, INC. | $25.39 | 2022 | |
| Cardiovascular Systems INC. | $18.93 | 2022 | |
| Nuwellis, INC. | $17.46 | 2021 | |
| Lexicon Pharmaceuticals, INC. | $17.10 | 2023 | Inpefa |
| Medicomp INC | $15.47 | 2021 | |
| Siemens Medical Solutions USA, INC. | $15.33 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $15.24 | 2023 | |
| Ge Healthcare | $13.68 | 2023 | |
| Baxter Healthcare | $13.32 | 2023 | Hillrom - Cardiac Ambulatory Monitor |
| Lantheus Medical Imaging, INC. | $13.07 | 2023 | Definity |
| Penumbra, INC. | $12.55 | 2022 | |
| Vital Connect, INC | $11.39 | 2022 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$68,405.82 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andreas Muench listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.